Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-097114
Filing Date
2025-10-06
Accepted
2025-10-06 16:15:21
Documents
15
Effectiveness Date
2025-10-06

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2527618d1_s8.htm S-8 81772
2 EXHIBIT 5.1 tm2527618d1_ex5-1.htm EX-5.1 8389
3 EXHIBIT 23.1 tm2527618d1_ex23-1.htm EX-23.1 2361
4 EX-FILING FEES tm2527618d1_ex-filingfees.htm   iXBRL EX-FILING FEES 16165
5 GRAPHIC tm2527618d1_ex5-1img001.jpg GRAPHIC 4950
  Complete submission text file 0001104659-25-097114.txt   235779

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2527618d1_ex-filingfees_htm.xml XML 4759
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-290731 | Film No.: 251377014
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)